These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 63624)

  • 1. [Products of fibrinogen splitting and their biological significance (literature survey)].
    Timoshenko LI
    Lab Delo; 1976; (9):515-20. PubMed ID: 63624
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis.
    Ambrus JL; Ambrus CM; Pickern J; Soldes S; Bross I
    J Med; 1975; 6(5-6):433-58. PubMed ID: 130433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemostatic mechanisms and malignant tumors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravascular blood coagulation and its role in malignant neoplasms].
    Pavlovskiĭ DP
    Vopr Onkol; 1981; 27(7):96-103. PubMed ID: 7023043
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal disease and fibrinogen degradation products.
    Hedner U; Nilsson IM
    Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravascular coagulation of the blood in liver cirrhosis (a review of the literature)].
    Shelest LIu; Sushko EA; Shkapko VD; Shekhter IE; Ena IaM
    Vrach Delo; 1990 Aug; (8):44-7. PubMed ID: 2256285
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of disseminated intravascular coagulation.
    Larrieu MJ
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):321-4. PubMed ID: 515795
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N; Aoki Y; Terada H
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of 2 tests for determining lytic products of fibrin].
    Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
    Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.
    Yoshioka K; Mizuno S; Miyata H; Maki S
    Eur J Pediatr; 1982 Feb; 138(1):46-8. PubMed ID: 7075627
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.